
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Ellex Medical Lasers Limited is a medical devices business based in Australia. Ellex Medical Lasers shares (ELX) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Ellex Medical Lasers has a trailing 12-month revenue of around $12.8 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Ellex Medical Lasers 's share price has had significant negative movement.
Its last market close was $0.32, which is 56.76% down on its pre-crash value of $0.74 and 42.19% down on the lowest point reached during the March crash when the shares fell as low as $0.455.
If you had bought $1,000 worth of Ellex Medical Lasers shares at the start of February 2020, those shares would have been worth $591.19 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $402.52.
52-week range | $0.285 - $0.9 |
---|---|
50-day moving average | $0.3224 |
200-day moving average | $0.4579 |
Target price | $1.69 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.248 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.32 on 2020-10-22
1 week (2021-01-12) | -5.88% |
---|---|
1 month (2020-12-18) | -4.48% |
3 months (2020-10-19) | 0% |
6 months (2020-07-17) | -52.94% |
1 year (2020-01-17) | -57.33% |
---|---|
2 years (2019-01-18) | -47.54% |
3 years (2018-01-19) | -67.68% |
5 years (2016-01-19) | -56.16% |
Valuing Ellex Medical Lasers stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ellex Medical Lasers 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ellex Medical Lasers 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $679,000 (£386,416).
The EBITDA is a measure of a Ellex Medical Lasers 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $12.8 million |
---|---|
Gross profit TTM | $9.7 million |
Return on assets TTM | -4.14% |
Return on equity TTM | -12.19% |
Profit margin | 279.22% |
Book value | 0.7 |
Market capitalisation | $102 million |
TTM: trailing 12 months
We're not expecting Ellex Medical Lasers to pay a dividend over the next 12 months.
Ellex Medical Lasers 's shares were split on a 1:5 basis on 10 July 2001. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ellex Medical Lasers shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Ellex Medical Lasers shares which in turn could have impacted Ellex Medical Lasers 's share price.
Over the last 12 months, Ellex Medical Lasers 's shares have ranged in value from as little as $0.285 up to $0.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Ellex Medical Lasers 's is 0.6182. This would suggest that Ellex Medical Lasers 's shares are less volatile than average (for this exchange).
Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.